Despite previous studies indicating the possibility of PRKAG2 as a candidate gene for early Parkinson’s disease [31], more robust evidence is still necessary, and more data regarding the role of AMPK in the pathophysiology of MND/ALS and Parkinson’s disease will enable a better understanding of pathogenesis [24]. This evidence concerns the gene PRKAG2 and mild neurocognitive disorder.